Treatment · July 26, 2026
Experimental Drug Shows Promise for Rare Blood Disorder with No Approved Treatments
New initiatives are addressing critical gaps in blood disorder treatment, research, and patient support....
Breakthrough · June 9, 2026
Experimental Compound Targets New Alzheimer’s Trigger in Brain Cells
Scientists identify a new Alzheimer's trigger and develop a drug to stop it, offering hope for prevention and treatment....
Treatment · May 26, 2026
Experimental Drug Cuts Tourette Syndrome Relapse Risk by Half in Children
New medication for Tourette Syndrome shows promise in Phase III clinical trials....